SPINAL MUSCULAR ATROPHY FOUNDATION
https://WWW.SMAFOUNDATION.ORGTotal Given 2016–2023
$13.2M
54 grants · $1.6M avg/year
based on 8 yrs of IRS 990-PF records on file
$1M+/yr
mid-tier
capacity
$138K
typical big bets · $84K–$282K
grant size
44%
supporter · 7/16 multi-year
repeat
$3.6M
Assets · 2020
16
Distinct recipients
Focus Areas
Application Information
Accepts Unsolicited Proposals
No — Preselected Only
Phone
6462537100
Financial Trends
Giving Over Time
Total Assets Over Time
View financial data as table
| Year | Total Giving | Total Assets | Revenue | Grants |
|---|---|---|---|---|
| 2016 | $2.7M | $3.9M | $6.5M | 15 |
| 2017 | $1.4M | $2.0M | $1.7M | 8 |
| 2018 | $2.2M | $3.0M | $5.2M | 8 |
| 2019 | N/A | $1.5M | $193K | N/A |
| 2020 | $1.4M | $3.6M | $3.4M | 5 |
| 2022 | $2.1M | $24.1M | $25.4M | 2 |
| 2023 | $3.3M | $33.7M | $12.5M | 16 |
Grant Size Distribution
Based on 54 grants on record
Minimum
$13K
25th Pctl
$84K
Median
$138K
Average
$244K
75th Pctl
$282K
Maximum
$1.4M
Geographic Distribution
Key Personnel
| Name | Title | Compensation |
|---|---|---|
| DINAKAR SINGH | BOARD CHAIRMAN | — |
| LOREN ENG | PRESIDENT | — |
| STORY LANDIS | DIRECTOR | — |
| SIMON PRISK ESQ | DIRECTOR | — |
| JULI OH ESQ | TREASURER | — |
| STEPHEN MIKITA ESQ | DIRECTOR | — |
| HELEN MEATES | DIRECTOR | — |
| JONATHAN LEFF | DIRECTOR | — |
| ANDREW KNIGHT | DIRECTOR | — |
| GERALD FISCHBACH MD | DIRECTOR | — |
| DOUGLAS COLE MD | DIRECTOR | — |
| DAVID WEIL ESQ - RESIGNED 051718 | TREASURER | — |
| DAVID WEIL ESQ | TREASURER | — |
| GERALD FISCHBACH M D | DIRECTOR | — |
| DOUGLAS COLE M D | DIRECTOR | — |
| SRIN MADIPALLI | DIRECTOR | — |
Grants Awarded (54 total)
| Purpose | ||||
|---|---|---|---|---|
| STANFORD UNIVERSITY | PALO ALTO, CA | $1,423,413 | MODAILTY-AGNOSTIC DRUG PROTOTYPING RESEARCH PROJECTS | 2022 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $1,100,000 | MODAILTY-AGNOSTIC DRUG PROTOTYPING RESEARCH PROJECTS | 2020 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $886,832 | ADVANCING DEVELOPMENT OF THERAPEUTICS FOR SMA | 2018 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $802,984 | ADVANCING DEVELOPMENT OF THERAPEUTICS FOR SMA | 2016 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $770,775 | CHARACTERIZATION OF NEURON-GLIAL-IMMUNE CELL INTERACTIONS IN SMA | 2023 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $653,689 | MODAILTY-AGNOSTIC DRUG PROTOTYPING RESEARCH PROJECTS | 2022 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $518,728 | OVERSIGHT ON THE STANFORD-SMA FOUNDATION REGENERATIVE MEDICINE PROGRAM PROJECTS | 2023 |
| UNIVERSITY OF SOUTHERN CALIFORNIA | LOS ANGELES, CA | $336,252 | EXAMINATION OF NEUROMUSCULAR JUNCTIONS IN SMA MICE | 2018 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $312,000 | DEVELOPMENT OF AN ASSAY FOR IMPROVEMENT OF MOTOR OUTCOME IN MOUSE MODEL OF SMA FOLLOWING IN VIVO TREATMENT | 2016 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $312,000 | DEVELOPMENT OF AN ARRAY FOR IMPROVEMENT OF MOTOR OUTCOME IN MOUSE MODEL OF SMA FOLLOWING IN VIVO TRE | 2017 |
| UNIVERSITY OF FLORIDA | GAINESVILLE, FL | $296,860 | CHARACTERIZATION OF MUSCLE ENVIRONMENT IN SMA | 2023 |
| UNIVERSITY OF SOUTHERN CALIFORNIA | LOS ANGELES, CA | $282,811 | EXAMINATION OF NEUROMUSCULAR JUNCTIONS IN SMA MICE | 2016 |
| UNIVERSITY OF SOUTHERN CALIFORNIA | LOS ANGELES, CA | $282,810 | EXAMINATION OF NEUROMUSCULAR JUNCTIONS IN SMA MICE | 2017 |
| UNIVERSITY OF EDINBURGH | $282,424 | CHARACTERIZATION OF NEUROMUSCULAR JUNCTIONS IN SMA | 2023 | |
| THE TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $276,569 | ADVANCING DEVELOPMENT OF THERAPEUTICS FOR SMA. | 2017 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $276,569 | ADVANCING DEVELOPMENT OF THERAPEUTICS FOR SMA | 2016 |
| CHILDREN'S HOSPITAL OF BOSTON | BOSTON, MA | $245,771 | ADVANCING DEVELOPMENT OF THERAPEUTICS FOR SMA | 2018 |
| JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | $229,777 | PATHOLOGY OF SMA | 2018 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $224,927 | CLINICAL RESEACH PROJECT | 2018 |
| CHILDREN'S HOSPITAL OF BOSTON | BOSTON, MA | $217,273 | ADVANCING DEVELOPMENT OF THERAPEUTICS FOR SMA. | 2017 |
| CHILDREN'S HOSPITAL OF BOSTON | BOSTON, MA | $217,273 | ADVANCING DEVELOPMENT OF THERAPEUTICS FOR SMA | 2016 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $207,000 | ANALYSIS OF GENE EXPRESSION AND SPLICING IN SMA PATIENT CELLS | 2023 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $207,000 | GENERATION OF SPINAL CORD MOTOR NEURONS FROM PLURIPOTENT CELLS | 2023 |
| STANFORD UNIVERSITY | PALO ALTO, CA | $162,935 | OVERSIGHT ON THE STANFORD-SMA FOUNDATION REGENERATIVE MEDICINE PROGRAM PROJECTS | 2023 |
| COLUMBIA UNIVERSITY | NEW YORK, NY | $150,000 | TO SUPPORT PNCR RESEARCH | 2020 |